Earnings Call · Q3 FY2025·2025-11-03

Q3 25EPS -17.54%·Rev n/aQ2 25EPS -4.09%·Rev n/aQ1 25EPS +10.36%·Rev n/aQ4 24EPS +10.67%·Rev n/a⚠ consensus missing

Karyopharm Therapeutics Inc. KPTI

Brendan Strong — Investor Relations or Communications Officer

Richard Paulson — Chief Executive Officer or Senior Executive

Reshma Rangwala — Medical or Clinical Executive

Sohanya Cheng — Commercial or Sales Executive

Lori Macomber — Chief Financial Officer or Finance Executive

+2.3%1d on move date+1.7% vs SPY3d−4.7%5d0.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KPTI calls or request research access.

More KPTI calls Browse calls Request research access